Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes.
Eur J Immunol
; 46(1): 230-41, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26518356
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocyte Subsets
/
CD8-Positive T-Lymphocytes
/
Diabetes Mellitus, Type 1
/
Antibodies, Monoclonal, Humanized
/
Transcriptome
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
Language:
En
Journal:
Eur J Immunol
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: